pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Episodes
![Ipsen on neurotoxin research: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9188274/pharmaphorum_podcast-Episode-7-1400x1400_300x300.jpg)
Thursday Mar 28, 2019
Thursday Mar 28, 2019
For episode 7 of the pharmaphorum podcast I spoke to Ipsen’s Philippe Picaut about neurotoxin research, with a particular focus on Botulinum neurotoxins.
![Successful medical marketing teams: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Friday Feb 22, 2019
Friday Feb 22, 2019
The pharmaphorum podcast’s first episode of 2019 features Professor Brian D Smith on what makes a modern, and successful, medical marketing team.
![Biotech strategy and nanomedicine: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Friday Dec 21, 2018
Friday Dec 21, 2018
For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
![Commercialising orphan drugs: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Tuesday Nov 20, 2018
Tuesday Nov 20, 2018
In episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Pharma, about its strategy and work in the rare diseases and gene therapy space.
![The future biosimilar landscape: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Tuesday Oct 16, 2018
Tuesday Oct 16, 2018
For episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet the head of the company’s UK specialty business Kavya Gopal.
![Nimble consumer healthcare innovation: the pharmaphorum podcast](https://pbcdn1.podbean.com/imglogo/image-logo/9188274/pharmaphorum_podcast-1400x1400_300x300.jpg)
Friday Sep 14, 2018
Friday Sep 14, 2018
In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.